CymitQuimica logo

(S)-10-Monohydroxy-10,11-dihydro carbamazepine

CAS:

Ref. 3D-FM26063

1g
382.00€
5g
1,085.00€
10g
1,627.00€
250mg
203.00€
500mg
305.00€
(S)-10-Monohydroxy-10,11-dihydro carbamazepine
Biosynth

    Product Information

    Name:(S)-10-Monohydroxy-10,11-dihydro carbamazepine
    Synonyms:
    • S-(+)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide(S)-Licarbazepine
    Brand:Biosynth
    Description:(S)-10-Monohydroxy-10,11-dihydro carbamazepine is a prodrug that is metabolized to carbamazepine. It has been shown to be effective in treating epilepsy in humans, with an optimum concentration of 20-30 micrograms/mL. The matrix effect of (S)-10-monohydroxy-10,11-dihydro carbamazepine can be reduced by sampling blood at different times of the day or by taking into account the levels of hepatic impairment or drug interactions. The optimal dose for human serum levels is between 8 and 25 micrograms/mL. (S)-10-Monohydroxy-10,11-dihydro carbamazepine may also be used to treat other conditions such as trigeminal neuralgia and postherpetic neuralgia.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:254.28 g/mol
    Formula:C15H14N2O2
    Purity:Min. 95%
    Color/Form:Powder

    Technical inquiry about: (S)-10-Monohydroxy-10,11-dihydro carbamazepine

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.